Study affirms value of epigenetic test for markers of prostate cancer
A multicenter team of researchers report that a commercial test designed to rule out the presence of genetic biomarkers of prostate cancer may be accurate enough to exclude the need for repeat prostate biopsies in many—if ...
May 28, 2014
0
0